Lonza Group AG (LONN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lonza Group AG (LONN) has a cash flow conversion efficiency ratio of 0.081x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF660.00 Million ≈ $834.42 Million USD) by net assets (CHF8.15 Billion ≈ $10.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Lonza Group AG (LONN) market capitalisation for the company's overall valuation and market capitalisation.
Lonza Group AG - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Lonza Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Lonza Group AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lonza Group AG ranked by their cash flow conversion efficiency. Explore Lonza Group AG earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Microchip Technology Inc
NASDAQ:MCHP
|
0.040x |
|
Powszechna Kasa Oszczednosci Bank Polski SA
WAR:PKO
|
0.037x |
|
LEGRAND UNSP.ARD 1/5 EO 4
F:LRC0
|
0.033x |
|
Legrand SA
PA:LR
|
0.059x |
|
EQT AB (publ)
ST:EQT
|
0.035x |
|
Flex Ltd
NASDAQ:FLEX
|
0.080x |
|
CSL LTD SPON.ADR 2
F:CSJA
|
N/A |
|
JD.com Inc Adr
NASDAQ:JD
|
0.002x |
Annual Cash Flow Conversion Efficiency for Lonza Group AG (2004–2025)
The table below shows the annual cash flow conversion efficiency of Lonza Group AG from 2004 to 2025. View LONN stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF9.19 Billion ≈ $11.61 Billion |
CHF1.17 Billion ≈ $1.48 Billion |
0.127x | -6.23% |
| 2024-12-31 | CHF9.39 Billion ≈ $11.87 Billion |
CHF1.27 Billion ≈ $1.61 Billion |
0.136x | -6.80% |
| 2023-12-31 | CHF9.51 Billion ≈ $12.03 Billion |
CHF1.39 Billion ≈ $1.75 Billion |
0.146x | +52.24% |
| 2022-12-31 | CHF10.66 Billion ≈ $13.48 Billion |
CHF1.02 Billion ≈ $1.29 Billion |
0.096x | -22.80% |
| 2021-12-31 | CHF9.82 Billion ≈ $12.42 Billion |
CHF1.22 Billion ≈ $1.54 Billion |
0.124x | -24.52% |
| 2020-12-31 | CHF6.88 Billion ≈ $8.70 Billion |
CHF1.13 Billion ≈ $1.43 Billion |
0.164x | +9.29% |
| 2019-12-31 | CHF6.57 Billion ≈ $8.30 Billion |
CHF986.00 Million ≈ $1.25 Billion |
0.150x | -12.69% |
| 2018-12-31 | CHF6.29 Billion ≈ $7.95 Billion |
CHF1.08 Billion ≈ $1.37 Billion |
0.172x | +26.43% |
| 2017-12-31 | CHF6.18 Billion ≈ $7.81 Billion |
CHF841.00 Million ≈ $1.06 Billion |
0.136x | -57.39% |
| 2016-12-31 | CHF2.35 Billion ≈ $2.98 Billion |
CHF752.00 Million ≈ $950.73 Million |
0.319x | -8.00% |
| 2015-12-31 | CHF2.13 Billion ≈ $2.70 Billion |
CHF741.00 Million ≈ $936.82 Million |
0.347x | +53.06% |
| 2014-12-31 | CHF2.13 Billion ≈ $2.69 Billion |
CHF483.00 Million ≈ $610.64 Million |
0.227x | -7.65% |
| 2013-12-31 | CHF2.13 Billion ≈ $2.69 Billion |
CHF522.00 Million ≈ $659.95 Million |
0.246x | -16.80% |
| 2012-12-31 | CHF2.41 Billion ≈ $3.04 Billion |
CHF710.00 Million ≈ $897.63 Million |
0.295x | +214.59% |
| 2011-12-31 | CHF2.36 Billion ≈ $2.98 Billion |
CHF221.00 Million ≈ $279.40 Million |
0.094x | -55.40% |
| 2010-12-31 | CHF2.39 Billion ≈ $3.02 Billion |
CHF502.00 Million ≈ $634.66 Million |
0.210x | +19.06% |
| 2009-12-31 | CHF2.39 Billion ≈ $3.02 Billion |
CHF422.00 Million ≈ $533.52 Million |
0.177x | +80.58% |
| 2008-12-31 | CHF1.79 Billion ≈ $2.26 Billion |
CHF175.00 Million ≈ $221.25 Million |
0.098x | -72.54% |
| 2007-12-31 | CHF1.81 Billion ≈ $2.29 Billion |
CHF644.00 Million ≈ $814.19 Million |
0.356x | +34.68% |
| 2006-12-31 | CHF1.61 Billion ≈ $2.03 Billion |
CHF425.00 Million ≈ $537.31 Million |
0.264x | -4.59% |
| 2005-12-31 | CHF1.49 Billion ≈ $1.88 Billion |
CHF413.00 Million ≈ $522.14 Million |
0.277x | +100.10% |
| 2004-12-31 | CHF1.28 Billion ≈ $1.62 Billion |
CHF178.00 Million ≈ $225.04 Million |
0.139x | -- |
About Lonza Group AG
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biol… Read more